Add like
Add dislike
Add to saved papers

The effect of interligand energy transfer on the emission spectra of heteroleptic Ir complexes.

In order to understand the causes of the emission shape and colour changes of heteroleptic Ir3+ complexes containing 2-(2,4-difluorophenyl)pyridine (dfppy) as the main ligands, we introduced two types of ancillary ligands: (1) non-luminescent ancillary ligands, namely tetrakis(pyrazolyl)borate (bor) and picolinate (pic), which were employed for the preparation of Ir(dfppy)2 (bor) and Ir(dfppy)2 (pic), respectively, and (2) luminescent ancillary ligands, namely 1,10-phenanthroline (phen), bipyridine (bpy), and 2,3-dipyridylpyrazine (dpp), which were employed for the preparation of Ir(dfppy)2 (phen), Ir(dfppy)2 (bpy), and Ir(dfppy)2 (dpp), respectively. In a glassy matrix at 77 K, the Ir complexes showed well-structured emission spectra, except Ir(dfppy)2 (dpp). The vibronic structures in the emission spectra of Ir(dfppy)2 (bor) and Ir(dfppy)2 (pic) were maintained even at 300 K. However, Ir(dfppy)2 (phen), Ir(dfppy)2 (bpy), and Ir(dfppy)2 (dpp) showed markedly red-shifted and broad emission spectra. The anomalous rigidochromism was attributed to an interligand energy transfer (ILET), and showed a strong temperature dependence. The excited states of dfppy are higher than those of phen, bpy, and dpp; thus, ILET occurs from dfppy to the other ligands lying in lower energy states. The ILET dynamics were probed directly using femtosecond transient absorption (TA) spectroscopy after the excitation of dfppy. As the time delay increased, the intensity of the TA band of dfppy decreased, while those of the bands related to the phen, bpy, and dpp ancillary ligands increased. On the other hand, no changes in the TA spectra were observed for Ir(dfppy)2 (bor) and Ir(dfppy)2 (pic). The TA spectral behaviours can be explained in terms of the relative ordering of the emissive states for cyclometalating and ancillary ligands.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app